Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
Horizon Lines: A Quarterly Review of NDAs – January-March, 2026
The NDAs approved during the first quarter of 2026 have been divided into the dosage forms Injection, Tablets, Capsules, Oral solution, Gas, and other. read more

View More Editorial Articles »

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

View More Videos »

View More Whitepapers & Application Notes »

Bora, Onconic Ink Manufacturing Deal for U.S. JAQBO Clinical Program
Thursday, July 23, 2026
Bora Pharmaceuticals and Onconic Therapeutics have signed a manufacturing agreement to support the U.S. clinical development of JAQBO tablets, a ... read more
ImmuPharma Selects Thermo Fisher Scientific Drug Product CDMO for Kapiglucagon Program
Wednesday, July 22, 2026
The selection of Thermo Fisher represents an important Chemistry, Manufacturing and Controls (“CMC”) milestone for the Kapiglucagon program and is ... read more
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufac-turing Partnership
Wednesday, July 22, 2026
Restore Vision and Forge Biologics, a manufacturer of gene therapies and member of Ajinomoto Bio-Pharma Services, announced a development and ... read more
Wheeler Bio Appoints Chief Development Officer
Wednesday, July 22, 2026
Wheeler Bio announced the appointment of Rajesh Beri, Ph.D., as Chief Development Officer. read more
Phanes, Merck Expand Trial Pact to Test CD47 Bispecific with KEYTRUDA in 1L Biliary Tract Cancer
Tuesday, July 21, 2026
Phanes Therapeutics has expanded its clinical trial collaboration and supply agreement with Merck to evaluate spevatamig in combination with KEYTRUDA ... read more

View More News »

Bora, Onconic Ink Manufacturing Deal for U.S. JAQBO Clinical Program
Thursday, July 23, 2026
ImmuPharma Selects Thermo Fisher Scientific Drug Product CDMO for Kapiglucagon Program
Wednesday, July 22, 2026
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufac-turing Partnership
Wednesday, July 22, 2026

April/May/June 2026

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

AI in GxP: Annex 11/22, Governance Models & Practical Use Cases
Wednesday, August 12, 2026
Modernizing Validation for Cloud and Hybrid GxP Systems
Wednesday, September 9, 2026
ChemOutsourcing 2026
Tuesday, September 15, 2026

View More Events »

2026 Company Focus & Industry Reference Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary magazine subscription